Title: Mortality rates and risk factors in 1,412 Japanese patients with decompensated hepatitis
C virus-related cirrhosis: A retrospective long-term cohort study
Version: 2 Date: 19 Feb 2021
Reviewer's report:
This study was performed focusing on the long-term prognosis of hepatitis C-related liver
cirrhosis.
However, multivariate analysis did not show any new findings related to survival. Most of the
parameters are well-known factors for poor prognosis. Hence, the authors need to search for a
new prognostic model to predict the patients’ outcomes. Another problem is that information
regarding the HCC stage and treatment is lacking. If the authors do not want to exclude patients
with HCC, they need to provide such data.
Title: Mortality rates and risk factors in 1,412 Japanese patients with decompensated hepatitis
C virus-related cirrhosis: A retrospective long-term cohort study
Version: 2 Date: 19 Feb 2021
Reviewer's report:
This study was performed focusing on the long-term prognosis of hepatitis C-related liver
cirrhosis.
However, multivariate analysis did not show any new findings related to survival. Most of the
parameters are well-known factors for poor prognosis. Hence, the authors need to search for a
new prognostic model to predict the patients’ outcomes. Another problem is that information
regarding the HCC stage and treatment is lacking. If the authors do not want to exclude patients
with HCC, they need to provide such data.
Please review this paper.
user
Title: Mortality rates and risk factors in 1,412 Japanese patients with decompensated hepatitis
C virus-related cirrhosis: A retrospective long-term cohort study
Version: 2 Date: 19 Feb 2021
Reviewer's report:
This study was performed focusing on the long-term prognosis of hepatitis C-related liver
cirrhosis.
However, multivariate analysis did not show any new findings related to survival. Most of the
parameters are well-known factors for poor prognosis. Hence, the authors need to search for a
new prognostic model to predict the patients’ outcomes. Another problem is that information
regarding the HCC stage and treatment is lacking. If the authors do not want to exclude patients
with HCC, they need to provide such data.
assistant